
Sign up to save your podcasts
Or


Send us Fan Mail
In this groundbreaking episode of 'The Just M.S. Show,' we embark on a stellar journey to the International Space Station with the National Stem Cell Foundation. Discover how the microgravity environment of space is providing unparalleled insights into neurodegenerative diseases like Primary Progressive Multiple Sclerosis and Parkinson's. Learn about the use of brain cell organoids in zero-gravity, which could unlock new treatment avenues. Dr. Paula Grisanti of the National Stem Cell Foundation guides us through this ambitious project, highlighting the potential for breakthroughs in medical science and the inspiring collaboration of international astronauts and researchers. This episode is a blend of space exploration, medical innovation, and human perseverance, offering hope and new possibilities in the fight against M.S.
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
In this enlightening episode of "The Just M.S. Show," we delve into a groundbreaking development in medical research. The focus is on the European Union's substantial investment in the PsyPal trial, a study exploring the potential of psilocybin therapy in treating multiple sclerosis (MS) and other serious conditions requiring palliative care. This episode sheds light on the holistic approach of the trial, its significance in the realm of psychedelic-assisted therapy, and its implications for enhancing the quality of life and psychological well-being of patients with chronic illnesses.
Link to original article:
https://www.benzinga.com/markets/cannabis/24/01/36788977/eu-allocates-6-5m-to-study-psychedelics-for-pulmonary-disorder-multiple-sclerosis-als-parkinsons
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
In this heartfelt episode of 'The Just M.S. Show,' I, Justin Loizos, share my recent experience with a medical infusion. Despite the challenges, including a decision to use a walker and some physical setbacks, the day was marked by moments of positivity and resilience. I discuss the ups and downs, from the amazing support of my nurse to the difficulties my body faced, such as my back giving out. I also touch on the improvements I've noticed, including a better bladder pill and the comfort of snacks. This episode isn't just about the physical journey; it's a deeper dive into the mental fortitude required to keep hope alive in the face of multiple sclerosis, especially during the tough times over the past months and years. Join me as I reflect on the importance of support systems like the hope program and MS peer groups, and how they help in not giving up hope, even when walking and standing have become significant challenges.
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
In this episode of The Just MS Show, we dive into the transformative power of the Exopulse Mollii Suit, a potential game-changer for those with MS-induced spasticity. Join us as we chat with Ida about her personal experience and how this innovation has made a difference in her life. Tune in for insights, stories, and the drive to empower the MS community.
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
In this enlightening episode of "The Just MS Show," we delve deep into the innovative realm of neurostimulation with the Exopulse Mollii Suit. Since first covering this groundbreaking technology on April 19, 2023, the buzz and anticipation surrounding its potential have been palpable. The Mollii Suit, equipped with 58 electrodes seamlessly embedded in its design, harnesses the power of neurostimulation to offer tailored relief to those grappling with spasticity. Through gentle electrical signals, it prompts a natural response in the body, aiding muscles to relax and function more organically. As we unpack the science behind this marvel, we'll also shed light on the profound impact it has on muscle groups that are often at odds due to spasticity, aiming to restore a harmonious balance.
But what truly brings our next episode to life is our heart-to-heart with Ida, a Mollii Suit user. Through her candid experiences, we gain insights into its transformative power and how it's revolutionizing the way we address the challenges of Multiple Sclerosis. As we anticipate trying the suit firsthand, join us in this journey of discovery, understanding, and hope for a future where mobility is not just a dream but an achievable reality for our MS community. Don't miss this deep dive into the Mollii Suit’s potential and its promise of a brighter, more mobile tomorrow.
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
In this week's comprehensive MS news digest, we begin with the uplifting journey of Dr. Antonio Barbera, who discovered therapeutic benefits in table tennis after his MS diagnosis. The spotlight then shifts to Genentech's pioneering strides in MS treatment, offering hope to many. Octave Bioscience's significant funding and its implications for precision MS care is another highlight. From South Africa, we unravel potential underestimations of MS cases, providing a fresh perspective on global MS data. The safety of the drug Copaxone during breastfeeding takes center stage in a vital segment, followed by an exploration of the societal challenges faced by Kristin Kliphuis, an MS patient wrongly accused of DUI. We conclude with a thought-provoking piece on the potential benefits of oral tobacco for MS progression. This round-up offers a blend of hope, innovation, and awareness for the MS community.
Show Notes: Weekly MS News Round-Up, Week of July 31st - Aug 6th
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
In this episode of The Just M.S. Show, we delve into the remarkable advances in the world of Multiple Sclerosis (MS) treatment and detection. From AI models predicting MS risk before symptoms appear to the groundbreaking addition of MS medications to WHO's Essential Medicines List, the hope for effective treatment is brighter than ever. We discuss the efficacy of ocrelizumab as a first-line treatment and the shift in disease-modifying therapy prescription towards oral medications. We also share personal stories of aging with MS, and the interplay between MS progression and normal aging processes. Finally, we explore fascinating research insights on how gut microbiome could trigger MS onset, and how Biogen's acquisition of Reata Pharmaceuticals might shape the future of rare disease treatments. Join us for these discussions and more as we navigate through the dynamic landscape of MS research, treatment, and personal experiences.
Intro – Justin kicks off the episode by introducing the listeners to the engaging content of the day which includes the latest breakthroughs in Multiple Sclerosis (MS) treatment, research, and personal experiences.
AI in Healthcare – Justin dives deep into a PRNewswire article highlighting the role of artificial intelligence (AI) and machine learning in predicting MS and minimizing laboratory errors.
https://www.prnewswire.com/news-releases/artificial-intelligence-models-predict-multiple-sclerosis-detect-contaminated-lab-samples-301883543.html
Essential Medicines Update – Discussion on the World Health Organization's new additions to the Model Lists of Essential Medicines for MS treatment, providing an analysis of how this could influence the lives of patients across the globe.
https://www.who.int/news/item/26-07-2023-who-endorses-landmark-public-health-decisions-on-essential-medicines-for-multiple-sclerosis
Ocrelizumab Efficacy – Detailed analysis of a Healio article revealing the effectiveness of ocrelizumab as a first-line treatment for MS, backed by a comprehensive 9-year research study.
https://www.healio.com/news/neurology/20230726/video-ocrelizumab-effective-as-firstline-treatment-for-ms
Aging with MS – In this heartfelt segment, Justin presents the narrative of Trevis Gleason from Everyday Health, where he shares his personal journey with aging and MS, which many listeners will relate to.
https://www.everydayhealth.com/columns/trevis-gleason-life-with-multiple-sclerosis/aging-with-ms/
Prescription Shifts – Delving into a study from HealthDay News, Justin discusses the noticeable shift towards oral disease-modifying therapies in MS treatment.
Gut Microbiome and MS – An exciting segment discussing research from Ludwig-Maximilians-Universität München about the relationship between the gut microbiome and the activation of auto-aggressive T cells in MS.
Biogen and Reata Acquisition – In the final part of the episode, Justin tackles Biogen's recent acquisition of Reata Pharmaceuticals, offering insights into how this might shape the future of the rare disease drugs market, including MS treatment.
https://www.washingtonpost.com/business/2023/07/28/biogen-deal-for-reata-signals-a-turn-to-rare-diseases/9cbf4a84-2d67-11ee-a948-a5b8a9b62d84_story.html
Outro – Wrapping up, Justin encourages the listeners to stay positive, informed, and connected, and invites them to join the next episode of "The Just M.S. Show".
Listeners are encouraged to refer to the episode description for links to all the articles discussed in this episode. Reviews and ratings on your preferred podcast platform are appreciated.
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
Welcome to another episode of The Just M.S. Show with your host, Justin Loizos! This week, we delve into the most significant multiple sclerosis (MS) stories from July 17th to 23rd. We begin with an in-depth discussion on a groundbreaking study that uncovers the limitations of twice-daily alertness tests in measuring fatigue in MS patients, providing vital insights for future fatigue assessment protocols. Next, we hear the inspiring story of Ida Curovac, an MS warrior who found strength and a new perspective on life through her journey with the illness. We then explore the complex relationship between MS and depression, backed by a study that suggests early depression is unlikely to increase disability in MS patients. In our quest for innovative treatments, we touch upon a cutting-edge research tool developed to fast-track the discovery of remyelination therapies, potentially heralding a new era in MS treatment. To conclude, we discuss a disturbing incident of medical tourism gone awry, a tale of caution for all considering experimental treatments abroad. And finally, we shed light on an encouraging study that emphasizes the importance of initiating MS treatment within the first six months of symptom onset to significantly reduce the risk of long-term disability.
Topic 1:
Topic 2:
Topic 3:
Topic 4:
Topic 5:
Topic 6:
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
Welcome to "The Just M.S. Show" with your host, Justin Loizos. In this episode, we delve into the world of multiple sclerosis (MS) and its profound impact on individuals and communities. Join us as we explore a series of news articles shedding light on the triumphs, challenges, and advancements in the field.
Here are the articles covered in this episode:
Resilient Actress Christina Applegate (Survivornet)
Link: [www.survivornet.com/articles/resilient-actress-christina-applegate-51-says-its-never-a-good-day-with-ms-but-she-pushes-on-for-her-family]
Ridgewood Mom Dies at 52; Spread Joy While Battling MS For 22 Years (Patch)
Link: [www.patch.com/new-jersey/ridgewood/ridgewood-mom-dies-52-spread-joy-while-battling-ms-22-years]
Thousands Swim for Multiple Sclerosis (Euro Weekly News)
Link: [www.euroweeklynews.com/2023/07/11/thousands-swim-for-multiple-sclerosis]
Brain Barrier Inflammation: A Stealthy Contributor to Multiple Sclerosis (eLife)
Link: [www.neurosciencenews.com/inflammation-multiple-sclerosis-23611]
Oral Medication Is the Leading Choice for Multiple Sclerosis Treatment (Rutgers University)
Link: [www.newswise.com/articles/oral-medication-is-the-leading-choice-for-multiple-sclerosis-treatment]
Global Interferon Market Report (ReportLinker)
Link: [www.finance.yahoo.com/news/global-interferon-market-report-global-174200075.html]
Positive Phase 3 Results Reported for Twice-Yearly Subcutaneous MS Therapeutic
Link: [www.breakinglatest.news/health/multiple-sclerosis-positive-results-from-subcutaneous-injection-of-ocrelizumab-twice-a-year]
Team Creates Open-Source Medicine Autoinjector (Science15)
Link: [www.miragenews.com/team-creates-open-source-medicine-autoinjector-1047409]
Make sure to visit the links to access the full articles and gather more information on each topic discussed.
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
Send us Fan Mail
Show Notes: JMSS –
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
From the publisher's feed
A podcast about multiple sclerosis hosted by Justin Loizos. Each episode will explore the world of MS. This will either be done through interviews with MS stakeholders or with Justin providing…